Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Lung Adenocarcinoma
Related studies linked through entity extraction aliases.
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAR T Cells in Mesothelin Expressing Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
Molecular Analysis of 150 Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
- Status
- UNKNOWN
- Phase
- N/A
Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
- Status
- UNKNOWN
- Phase
- PHASE1
Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Blood Detection of EGFR Mutation For Iressa Treatment
- Status
- UNKNOWN
- Phase
- NA
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Whole-Exome Sequencing (WES) of Cancer Patients
- Status
- COMPLETED
- Phase
- N/A